Issue 44, 2014

Halogen-bond driven co-crystallization of potential anti-cancer compounds: a structural study

Abstract

The halogen-bonding ability of a series of bis-pyridine based pharmaceutically active ingredients is explored and the structural behaviour of co-crystals thereof is compared with that of their hydrogen-bonded analogues. All co-crystals are analysed using IR spectroscopy and thirteen new crystal structures comprising iodoperfluoroalkanes and bis-pyridineacetamides are presented. Binding preferences, structural patterns and correlations between molecular and crystal structures are discussed in the context of both hydrogen- and halogen bonds.

Graphical abstract: Halogen-bond driven co-crystallization of potential anti-cancer compounds: a structural study

Supplementary files

Article information

Article type
Paper
Submitted
04 Aug 2014
Accepted
19 Sep 2014
First published
03 Oct 2014

CrystEngComm, 2014,16, 10203-10209

Halogen-bond driven co-crystallization of potential anti-cancer compounds: a structural study

C. B. Aakeröy, D. Welideniya, J. Desper and C. Moore, CrystEngComm, 2014, 16, 10203 DOI: 10.1039/C4CE01614A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements